Evaluation of Safety Profile of Rituximab plus Lenalidomide Protocol in Frail Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

被引：0
|
作者：
Sevgili, Bahar [1 ]
Pashayev, Tural [2 ]
Bozer, Denis Sabriye [1 ]
Gunes, Ajda [1 ]
Karacadag, Fatma Keklik [3 ]
Saydam, Guray [1 ]
机构：
[1] Ege Univ, Dept Hematol, Fac Med, Izmir, Turkiye
[2] Liv Bona Dea Hosp, Dept Hematol, Baku, Azerbaijan
[3] Tepecik Res & Educ Hosp, Dept Hematol, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
relapsed or refractory; diffuse large B-cell lymphoma; partial response; case;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-152
引用
收藏
页码：S420 / S421
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Qing, Miao
    Huang, Yongfen
    Chen, Can
    Wang, Lingling
    Feng, Jun
    Xu, Chuanhai
    Cheng, Yuexin
    Dong, Jianming
    Zhang, Linlin
    Xu, Hao
    BLOOD, 2022, 140 : 3769 - 3770
  • [32] Magrolimab in Combination with Rituximab plus Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Maakaron, Joseph
    Asch, Adam S.
    Popplewell, Leslie L.
    Collins, Graham P.
    Flinn, Ian W.
    Ghosh, Nilanjan
    Keane, Colin
    Ku, Matthew
    Mehta, Amitkumar
    Roschewski, Mark
    O'Hear, Carol
    Ren, Xuehan
    Villa, Bertha
    Lal, Indu
    Smith, Sonali M.
    Advani, Ranjana H.
    BLOOD, 2022, 140 : 3728 - 3730
  • [33] Azacytidine plus rituximab-gemcitabine-oxaliplatin as salvage treatment in patients with relapsed/ refractory diffuse large B-cell lymphoma
    Meng Fanqiao
    Xiang Maoyuan
    Peng Cuicui
    Liu Yu
    Zeng Dongfeng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S453 - S453
  • [34] Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma
    Ivanov, Vadim
    Coso, Diane
    Aurran, Therese
    Schiano, Jean Marc
    Stoppa, Anne-Marie
    Rey, Jerome
    Broussais, Florence
    Blaise, Didier
    Bouabdallah, Reda
    BLOOD, 2012, 120 (21)
  • [35] Evaluation of the impact of maintenance rituximab in elderly patients with diffuse large B-cell lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 456 - 457
  • [36] Estimation of Long-Term Survival with Tafasitamab plus Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Salles, Gilles
    Goswami, Budhaditya
    Bagnardi, Vincenzo
    Dey, Debarshi
    Winderlich, Mark
    Ambarkhane, Sumeet
    Huang, Dan
    Nowakowski, Grzegorz S.
    BLOOD, 2020, 136
  • [37] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    Current Oncology Reports, 2003, 5 (5) : 357 - 357
  • [38] A phase 2 study of polatuzumab vedotin plus bendamustine plus rituximab in relapsed/refractory diffuse large B-cell lymphoma
    Terui, Yasuhito
    Rai, Shinya
    Izutsu, Koji
    Yamaguchi, Motoko
    Takizawa, Jun
    Kuroda, Junya
    Ishikawa, Takayuki
    Kato, Koji
    Suehiro, Youko
    Fukuhara, Noriko
    Ohmine, Ken
    Goto, Hideki
    Yamamoto, Kazuhito
    Kanemura, Nobuhiro
    Ueda, Yasunori
    Ishizawa, Kenichi
    Kumagai, Kyoya
    Kawasaki, Atsuko
    Saito, Tomohisa
    Hashizume, Misato
    Shibayama, Hirohiko
    CANCER SCIENCE, 2021, 112 (07) : 2845 - 2854
  • [39] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis
    Merchionne, Francesca
    Quintana, Giovanni
    Gaudio, Francesco
    Minoia, Carla
    Specchia, Giorgina
    Guarini, Attilio
    Quarta, Giovanni
    Pavone, Vincenzo
    Melpignano, Angela
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1446 - 1450
  • [40] Brentuximab vedotin in combination with lenalidomide and rituximab in subjects with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) (Trials in Progress).
    Bartlett, Nancy L.
    Yasenchak, Christopher A.
    Ashraf, Khaleel K.
    Harwin, William N.
    Sims, Robert Brownell
    Nowakowski, Grzegorz S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345